Circulating vaccine derived polio virus type 2 outbreak and response in Yemen, 2021-2022, a retrospective descriptive analysis
- PMID: 38491425
- PMCID: PMC10943856
- DOI: 10.1186/s12879-024-09215-1
Circulating vaccine derived polio virus type 2 outbreak and response in Yemen, 2021-2022, a retrospective descriptive analysis
Abstract
Background: The outbreaks of circulating Vaccine Derived Polio Viruses (cVDPVs) have emerged as a major challenge for the final stage of polio eradication. In Yemen, an explosive outbreak of cVDPV2 was reported from August 2021 to December 2022. This study aims to compare the patterns of cVDPV2 outbreak, response measures taken by health authorities, and impacts in southern and northern governorates.
Method: A retrospective descriptive study of confirmed cases of VDPV2 was performed. The data related to cVDPV2 as well as stool specimens and environmental samples that were shipped to WHO-accredited labs were collected by staff of surveillance. Frequencies and percentages were used to characterize and compare the confirmed cases from the southern and northern governorates. The average delayed time as a difference in days between the date of sample collection and lab confirmation was calculated.
Results: The cVDPV2 was isolated from 227 AFP cases reported from 19/23 Yemeni governorates and from 83% (39/47) of environmental samples with an average of 7 months delayed from sample collection. However, the non-polio AFP (NPAFP) and adequate stool specimen rates in the north were 6.7 and 87% compared to 6.4 and 87% in the south, 86% (195) and 14%(32) out of the total 227 confirmed cases were detected from northern and southern governorates, respectively. The first and second cases of genetically linked isolates experienced paralysis onset on 30 August and 1st September 2021. They respectively were from Taiz and Marib governorates ruled by southern authorities that started vaccination campaigns as a response in February 2022. Thus, in contrast to 2021, the detected cases in 2022 from the total cases detected in the south were lower accounting for 22% (7 of 32) of compared to 79% (155 of 195) of the total cases the north.
Conclusion: A new emerging cVDPV2 was confirmed in Yemen. The result of this study highlighted the impact of vaccination campaigns in containing the cVDPV2 outbreak. Maintaining a high level of immunization coverage and switching to nOPV2 instead of tOPV and mOPV2 in campaigns are recommended and environmental surveillance should be expanded in such a risky country.
Keywords: 2022; Circulating Vaccine Derived Polio Virus Type 2; Outbreak; Yemen.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Circulating vaccine derived polio virus type 1 outbreak, Saadah governorate, Yemen, 2020.BMC Infect Dis. 2022 Apr 29;22(1):414. doi: 10.1186/s12879-022-07397-0. BMC Infect Dis. 2022. PMID: 35488227 Free PMC article.
-
Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study.Lancet Infect Dis. 2024 Apr;24(4):427-436. doi: 10.1016/S1473-3099(23)00688-6. Epub 2024 Jan 18. Lancet Infect Dis. 2024. PMID: 38246190
-
Vaccine-derived poliovirus serotype 2 outbreaks and response in the Democratic Republic of the Congo, 2017-2021.Vaccine. 2023 Apr 6;41 Suppl 1(Suppl 1):A35-A47. doi: 10.1016/j.vaccine.2023.02.042. Epub 2023 Mar 11. Vaccine. 2023. PMID: 36907733 Free PMC article.
-
The immediate impact of the COVID-19 pandemic on polio immunization and surveillance activities.Vaccine. 2023 Apr 6;41 Suppl 1:A2-A11. doi: 10.1016/j.vaccine.2021.10.028. Epub 2021 Oct 22. Vaccine. 2023. PMID: 34756614 Free PMC article. Review.
-
Threat of resurgence or hope for global eradication of poliovirus?Curr Opin Neurol. 2023 Jun 1;36(3):229-237. doi: 10.1097/WCO.0000000000001156. Epub 2023 Apr 18. Curr Opin Neurol. 2023. PMID: 37078665 Review.
Cited by
-
Monitoring the VDPV2 outbreak in Egypt during 2020-2021 highlights the crucial role of environmental surveillance and boosting immunization in combating Poliovirus.BMC Infect Dis. 2024 Aug 26;24(1):866. doi: 10.1186/s12879-024-09731-0. BMC Infect Dis. 2024. PMID: 39187787 Free PMC article.
References
-
- GPEI. GPEI-Circulating vaccine-derived poliovirus. 2023.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous